People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Manufacturing / Industrial, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EXCELLOS, Inc | — | Biotechnology | Series B | $20.0M | $52.9M | 2021 |
| Argonaut Manufacturing Services, Inc. | — | Manufacturing / Industrial | Series A | $17.3M | $89.9M | 2016 |
| Panome Bio Inc. | — | Biotechnology | Series A | $12.0M | $26.3M | 2023 |
| Nimble Therapeutics, Inc. | — | Biotechnology | Series A | $10.0M | $361.5M | 2019 |
| Aquaro Histology, Inc. | — | Biotechnology | Series A | $9.8M | $354.7M | 2017 |
| NEXUS Biosystems, Inc. | — | Other Technology | Series A | $5.0M | $138.7M | 2009 |
DEVAL LASHKARI at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DEVAL LASHKARI on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rob Hart | 2 | 5 |
| PAUL GROSSMAN | 2 | 3 |
| Alexander Herzick | 2 | 3 |
| Jack Ball | 1 | 10 |
| David Smoller | 1 | 6 |
| Patrick Yount | 1 | 4 |
| Thomas Raffin | 1 | 4 |
| Edward Weinstein | 1 | 3 |
| GLENN NOVOTNY | 1 | 2 |
| Jigar Patel | 1 | 2 |
| David Wellis, Ph.D. | 1 | 2 |
| John Lillig | 1 | 2 |
| Tom Cohen | 1 | 2 |
| Rob Capone | 1 | 2 |
| Alex Herzik | 1 | 1 |
| Deval Lashkani | 1 | 1 |
| Alberto Elli | 1 | 1 |
| WAYNE WOODARD | 1 | 1 |
| Brenda Magill | 1 | 1 |
| RICK HANCOCK | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.